Li Hong-shan, Feng Qin, Hu Yi-yang, Chen Shao-dong, Peng Jing-hua, Li Xue-mei, Xu Li-li
Institute of Liver Disease, Shuguang Hospital, Shanghai University of TCM, Shanghai 201203, China.
Zhonghua Gan Zang Bing Za Zhi. 2009 Nov;17(11):826-30.
To investigate the role of adiponectin (ADP) and adiponectin receptor 2 (adipoR2) in pathology of fatty liver, and to investigate the effect of Chinese herbal decoction (Qushi Huayu Decoction, QHD) on fatty liver disease.
Two experimental fatty liver models were used. One was induced with high-fat diet for ten weeks, and the rats were divided into normal, model and QHD group, the QHD group was administrated with QHD during the last four weeks. The other experimental fatty liver model was induced by subcutaneous injection of carbon tetrachloride (CCl4) in combination with high-fat and low-protein diet for four weeks, and the rats were also divided into normal, model and QHD group, the QHD group was administrated with QHD during the last two weeks. The observation items include: (1) hepatic steatosis (H.E. staining); (2) serum ADP, hepatic triglyceride (TG), free fatty acid (FFA) and adipoR2; (3) correlation among serum ADP content, hepatic TG, FFA and adipoR2.
(1) Serious hepatic steatosis, increased hepatic TG and FFA, decreased serum ADP and hepatic adipoR2 were observed in the two models (P less than 0.01). QHD administration significantly reduced the hepatic TG and FFA, and increased serum ADP and hepatic adipoR2 (P less than 0.01) in these two models. (2) Inverse correlation was observed between hepatic TG, FFA and serum ADP, hepatic adipoR2 in these two models.
(1) Decreased serum ADP and hepatic adipR2 may play important roles in pathological process of fatty liver. (2) QHD administration increased the serum ADP and hepatic adipoR2.
探讨脂联素(ADP)及脂联素受体2(adipoR2)在脂肪肝病理中的作用,并研究中药复方(祛湿化瘀方,QHD)对脂肪肝疾病的影响。
采用两种实验性脂肪肝模型。一种通过高脂饮食诱导10周,将大鼠分为正常组、模型组和QHD组,QHD组在最后4周给予QHD。另一种实验性脂肪肝模型通过皮下注射四氯化碳(CCl4)联合高脂低蛋白饮食诱导4周,大鼠同样分为正常组、模型组和QHD组,QHD组在最后2周给予QHD。观察指标包括:(1)肝脏脂肪变性(苏木精-伊红染色);(2)血清ADP、肝脏甘油三酯(TG)、游离脂肪酸(FFA)及adipoR2;(3)血清ADP含量、肝脏TG、FFA及adipoR2之间的相关性。
(1)在两种模型中均观察到严重的肝脏脂肪变性、肝脏TG和FFA升高、血清ADP降低以及肝脏adipoR2降低(P<0.01)。给予QHD可显著降低这两种模型中肝脏的TG和FFA,并升高血清ADP和肝脏adipoR2(P<0.01)。(2)在这两种模型中,肝脏TG、FFA与血清ADP、肝脏adipoR2之间呈负相关。
(1)血清ADP和肝脏adipR2降低可能在脂肪肝的病理过程中起重要作用。(2)给予QHD可升高血清ADP和肝脏adipoR2。